Trillium Therapeutics Inc.

Trillium Therapeutics Inc.

TRIL.TO
Trillium Therapeutics Inc.CA flagToronto Stock Exchange
23.33
CAD
- -
- -

Trillium Therapeutics Inc. (TRIL.TO) Stock Split History

Learn about Trillium Therapeutics Inc.'s most recent 1-for-30 basis stock split on November 20, 2014. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Trillium Therapeutics Inc.'s most recent stock split

Split Date: 2014-11-20
Split Ratio: 1:30
Price Before Split: N/A
Price After Split: N/A

Developer API

Get TRIL.TO split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/TRIL.TO

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 30.00 times fewer shares (a 1:30 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Trillium Therapeutics Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2014-11-201:30YesN/AN/A
2013-02-061:10YesN/AN/A

About Trillium Therapeutics Inc.

Company overview and industry information

Trillium Therapeutics Inc. (TRIL.TO) operates in the Biotechnology industry. The recent 1-for-30 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Trillium Therapeutics Inc. Summary

Last updated: 7/7/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.